Loading...

Brian Jonas

TitleAsst Prof
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rosenberg AS, Brunson A, Jonas B, Keegan THM, Wun T. Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma. J Natl Cancer Inst. 2018 Jun 11. PMID: 29897481.
      View in: PubMed
    2. Wung W, Ananthakrishnan S, Jonas B. Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio. J Investig Med High Impact Case Rep. 2018 Jan-Dec; 6:2324709618764207. PMID: 29568782.
      View in: PubMed
    3. Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg AS, Jonas B, Keegan THM. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California. Cancer. 2018 May 01; 124(9):1938-1945. PMID: 29451695.
      View in: PubMed
    4. DiNardo CD, Pratz KW, Letai A, Jonas B, Wei AH, Thirman M, Arellano M, Frattini MG, Kantarjian H, Popovic R, Chyla B, Xu T, Dunbar M, Agarwal SK, Humerickhouse R, Mabry M, Potluri J, Konopleva M, Pollyea DA. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study. Lancet Oncol. 2018 Feb; 19(2):216-228. PMID: 29339097.
      View in: PubMed
    5. Kjelland JD, Dwyre DM, Jonas B. Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia. Case Rep Hematol. 2017; 2017:3625946. PMID: 29158926.
      View in: PubMed
    6. Jonas B. On the origin of relapse in AML. Sci Transl Med. 2017 Jul 12; 9(398). PMID: 28701479.
      View in: PubMed
    7. Jonas B. A new therapeutic target for myelofibrosis is cause for Gli. Sci Transl Med. 2017 May 31; 9(392). PMID: 28566426.
      View in: PubMed
    8. Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas B, Flowers CR, Keegan THM. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. Br J Haematol. 2017 07; 178(1):72-80. PMID: 28542862.
      View in: PubMed
    9. Jonas B. Combination of an oncolytic virus with PD-L1 blockade keeps cancer in check. Sci Transl Med. 2017 04 19; 9(386). PMID: 28424330.
      View in: PubMed
    10. Ho G, Jonas B, Li Q, Brunson A, Wun T, Keegan THM. Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia. Br J Haematol. 2017 06; 177(5):791-799. PMID: 28419422.
      View in: PubMed
    11. Jonas B. From MDS/AML to iPSC and back again. Sci Transl Med. 2017 Mar 08; 9(380). PMID: 28275157.
      View in: PubMed
    12. Swords RT, Greenberg PL, Wei AH, Durrant S, Advani AS, Hertzberg MS, Jonas B, Lewis ID, Rivera G, Gratzinger D, Fan AC, Felsher DW, Cortes JE, Watts JM, Yarranton GT, Walling JM, Lancet JE. KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study. Leuk Res. 2016 11; 50:123-131. PMID: 27736729.
      View in: PubMed
    13. Su RJ, Jonas B, Welborn J, Gregg JP, Chen M. Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol (N Y). 2016 Sep; 5:6-9. PMID: 27458550.
      View in: PubMed
    14. Jonas B, Johnson C, Gratzinger D, Majeti R. Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity. PLoS One. 2016; 11(7):e0159189. PMID: 27428079; PMCID: PMC4948781.
    15. Jonas B, Medeiros BC. Individualizing Therapeutic Strategies in Acute Myeloid Leukemia: Moving Beyond the 'One-Size-Fits-All' Approach. Oncology (Williston Park). 2016 Apr; 30(4):330, 333. PMID: 27085331.
      View in: PubMed
    16. Ali SF, Sonu RJ, Dwyre DM, Jonas B, Rashidi HH. Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome. Case Rep Hematol. 2015; 2015:318545. PMID: 26798525; PMCID: PMC4698528.
    17. Stelling A, Jonas B, Rashidi HH, Abedi M, Chen M. Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis. Cancers (Basel). 2015 Dec 14; 7(4):2459-65. PMID: 26694466; PMCID: PMC4695903.
    18. Song JY, Khojeini EV, Dwyre DM, Jonas B. B lymphoblastic leukemia with granules mimicking acute myeloid leukemia. Int J Hematol. 2015 Sep; 102(3):251-2. PMID: 26187696.
      View in: PubMed
    19. Sonu RJ, Jonas B, Dwyre DM, Gregg JP, Rashidi HH. Optimal Molecular Methods in Detecting p190 (BCR-ABL) Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature. Case Rep Hematol. 2015; 2015:458052. PMID: 25949834; PMCID: PMC4407518.
    20. McCoach CE, Rogers JG, Dwyre DM, Jonas B. Paraneoplastic Leukemoid Reaction as a Marker of Tumor Progression in Non-Small Cell Lung Cancer. Cancer Treat Commun. 2015; 4:15-18. PMID: 25932381.
      View in: PubMed
    21. Jonas B, Greenberg PL. MDS prognostic scoring systems – past, present, and future. Best Pract Res Clin Haematol. 2015 Mar; 28(1):3-13. PMID: 25659725; PMCID: PMC4324398.
    22. Zhang H, Li Y, Lin TY, Xiao K, Haddad AS, Henderson PT, Jonas B, Chen M, Xiao W, Liu R, Lam KS, Pan CX. Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin. Nanomedicine (Lond). 2014; 9(12):1807-20. PMID: 24628688; PMCID: PMC4167557.
    23. Goodson ML, Mengeling BJ, Jonas B, Privalsky ML. Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation. J Biol Chem. 2011 Dec 30; 286(52):44988-99. PMID: 22065574; PMCID: PMC3247966.
    24. Jonas B, Varlakhanova N, Hayakawa F, Goodson M, Privalsky ML. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing. Mol Endocrinol. 2007 Aug; 21(8):1924-39. PMID: 17519355; PMCID: PMC2675559.
    25. Goodson M, Jonas B, Privalsky MA. Corepressors: custom tailoring and alterations while you wait. Nucl Recept Signal. 2005; 3:e003. PMID: 16604171; PMCID: PMC1402215.
    26. Goodson ML, Jonas B, Privalsky ML. Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors. J Biol Chem. 2005 Mar 04; 280(9):7493-503. PMID: 15632172; PMCID: PMC2720035.
    27. Jonas B, Privalsky ML. SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways. J Biol Chem. 2004 Dec 24; 279(52):54676-86. PMID: 15491994; PMCID: PMC2653424.